| Literature DB >> 10850405 |
R Jelliffe1, A Schumitzky, M Van Guilder.
Abstract
As clinicians acquire experience with the clinical and pharmacokinetic behavior of a drug, it is usually optimal to record this experience in the form of a population pharmacokinetic model, and then to relate the behavior of the model to the clinical effects of the drug or to a linked pharmacodynamic model. The role of population modeling is thus to describe and record clinical experience with the behavior of a drug in a certain group or population of patients or subjects.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10850405 DOI: 10.1097/00007691-200006000-00019
Source DB: PubMed Journal: Ther Drug Monit ISSN: 0163-4356 Impact factor: 3.681